1. Lamanna JJ, Miller JH, Riley JP, Hurtig CV, Boulis NM. Cellular therapeutics delivery to the spinal cord: technical considerations for clinical application. Ther Deliv. 2013;4(11):1397–410.
2. Chen KS, McGinley LM, Kashlan ON, Hayes JM, Bruno ES, Chang JS, et al. Targeted intraspinal injections to assess therapies in rodent models of neurological disorders. Nat Protoc. 2019;14(2):331–49.
3. Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R, et al. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg Spine. 2005;3(3):173–81.
4. Levi AD, Okonkwo DO, Park P, Jenkins AL 3rd, Kurpad SN, Parr AM, et al. Emerging safety of intramedullary transplantation of human neural stem cells in chronic cervical and thoracic spinal cord injury. Neurosurgery. 2018;82(4):562–75.
5. Kutikov AB, Moore SW, Layer RT, Podell PE, Sridhar N, Santamaria AJ, et al. Method and apparatus for the automated delivery of continuous neural stem cell trails into the spinal cord of small and large animals. Neurosurgery. 2019;85(4):560–73.